Pfizer executive brings strong scientific and medical expertise to Agilent board SANTA CLARA, Calif. —  Agilent Technologies, Inc. (NYSE: A) today announced that Dr. Mikael Dolsten, chief scientific officer and president, Worldwide Research, Development and Medical, Pfizer Inc. has been elected to Agilent’s board of directors, effective Sept. 21, 2021. Dr. Dolsten brings 30 years […]

CHARLOTTESVILLE, Va. — BrightSpec, Inc. announced today the appointment of R. Terry Dunlay to the Board of Directors, effective as of September 1, 2021. Mr. Dunlay brings more than 30 years of life science industry experience. Terry was the founder and CEO of IntelliCyt Corporation which developed instrumentation, software, and reagents for immunology and immuno-oncology applications. IntelliCyt was acquired […]

BRANFORD, Conn. — IsoPlexis, a leader in functional single-cell proteomics, today announced the appointment of Dr. Jason Myers to its Board of Directors. Dr. Myers joins IsoPlexis’ Board of Directors with a wealth of experience in genomics, product development, and business leadership. Dr. Myers is the Chief Executive Officer at GenapSys, and a former board member of Invitae […]

MARLBOROUGH, Mass. — Akoya Biosciences, Inc. (NASDAQ: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the appointment of Myla Lai-Goldman, MD, a true pioneer and leader in the diagnostic industry, to its board of directors. “It is an honor to join the board of Akoya, a company that is providing innovative spatial biology solutions with […]

Highly accomplished technology CEO to accelerate the Company’s immense scale and capitalize on unprecedented momentum Bishop’s Stortford, UK: Dotmatics Ltd, an Insightful Science company that provides leading scientific informatics software to drive the automation of lab data workflows and accelerate critical R&D discovery, announced today the appointment of Mike McKee as its new President. McKee is an experienced CEO […]

Appointment brings extensive pharmaceutical services and Board experience to drive commercial growth and development of new products to improve speed, efficiency, and productivity of drug discovery CAMBRIDGE, UK: Optibrium™, a developer of software for drug discovery, today announced the appointment of Professor Andy Black as non-executive Chair of its Board of Directors. Following the company’s recent […]

Experienced senior leader brings proven track record of developing financial strategies that drive operational excellence and accelerate global expansion MONHEIM AM RHEIN, Germany – Resolve Biosciences, the pioneer in Molecular Cartography™, today announced the appointment of Erik Wiberg as Chief Financial Officer. In this role, Mr. Wiberg will report to Co-founder and CEO Jason T. Gammack […]

REDWOOD CITY, Calif. — GenapSys (Genapsys), a company developing a highly accurate and scalable electronic sequencing platform, today announced the additions of Priya Ray and Peter Swider to the Company’s leadership team as well as the launch of the company’s new branding and corporate website, www.genapsys.com. “We are pleased to welcome Priya and Peter to our accomplished and growing leadership team,” said Jason Meyers, […]

REDWOOD CITY, Calif. — Genapsys, Inc. (Genapsys), a company developing a highly accurate and scalable electronic sequencing platform, today announced the additions of Priya Ray and Peter Swider to the Company’s leadership team as well as the launch of the company’s new branding and corporate website, www.genapsys.com. “We are pleased to welcome Priya and Peter […]

Kadia joins Board as an Independent Director who brings significant expertise in commercializing disruptive life science technologies EMERYVILLE, Calif. — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Siddhartha Kadia, Ph.D. joined the Berkeley Lights Board of Directors as an independent director, effective September 7, 2021. “I am excited […]